Grants and Contributions:
Title:
ICAP 2024 – International Co-Innovation Action Plan
Agreement Number:
1016948
Agreement Value:
$50,000.00
Agreement Date:
Apr 1, 2024 - Oct 31, 2024
Description:
This International Co-Innovation Action Program (ICAP) project will prepare the firm to enter into future international co-innovation work.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
New Westminster, British Columbia, CA V3M 6B9
Reference Number:
172-2024-2025-Q1-1016948
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
732113931
Recipient Type:
For-profit organization
Recipient's Operating Name:
Eyam Vaccines and Immunotherapeutics Ltd.
Recipient's Legal Name:
Eyam Vaccines and Immunotherapeutics Ltd.
Federal Riding Name:
New Westminster--Burnaby
Federal Riding Number:
59019
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710